VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemesMarketEarningsCompareWatchlistInsider
IQVIQVIA Holdings Inc.
$167.77$28.5B
Research
OverviewAnalysis
Valuation
ValuationTargetsPrice
Financials
RevenueEarningsP/ERatiosDividend
Ownership
Holders
Tools
Total ReturnDCA Calculator
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

Follow VCP Scanner on XFollow VCP Scanner on LinkedIn
© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
  1. Home
  2. Financial Ratios

  1. Home
  2. IQV
  3. Financial Ratios

IQVIA Holdings Inc. (IQV) Financial Ratios

15 years of historical data (2011–2025) · Healthcare · Medical - Diagnostics & Research

View Quarterly Ratios →

P/E Ratio
↓
21.40
↓-40% vs avg
5yr avg: 35.91
08%ile100
30Y Low16.6·High160.9
View P/E History →
EV/EBITDA
↓
12.44
↓-31% vs avg
5yr avg: 18.07
00%ile100
30Y Low12.6·High24.9
P/FCF
↓
13.88
↓-39% vs avg
5yr avg: 22.68
00%ile100
30Y Low16.6·High36.9
P/B Ratio
↓
4.39
↓-37% vs avg
5yr avg: 6.95
030%ile100
30Y Low1.3·High9.1
ROE
↑
21.4%
↓+6% vs avg
5yr avg: 20.2%
080%ile100
30Y Low3%·High23%
Debt/EBITDA
↑
4.71
+4% vs avg
5yr avg: 4.52
060%ile100
30Y Low3.2·High7.7

Percentile shows where the current value sits in 30-year historical distribution. Sparklines show 5-year trend.

IQV Valuation Multiples

Price-based multiples — how expensive the stock is relative to earnings, sales, book value, and cash flow

IQVIA Holdings Inc. trades at 21.4x earnings, 40% below its 5-year average of 35.9x, sitting at the 8th percentile of its historical range. This is roughly in line with the Healthcare sector median P/E of 22.1x. On a free-cash-flow basis, the stock trades at 13.9x P/FCF, 39% below the 5-year average of 22.7x.

MetricTTMFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016
Market Cap$28.5B$39.1B$36.0B$43.1B$39.1B$55.0B$34.9B$30.8B$24.2B$21.8B$11.6B
Enterprise Value$42.7B$53.3B$48.5B$55.6B$50.8B$66.1B$46.0B$42.0B$34.3B$31.1B$17.6B
P/E Ratio →21.4028.7526.2431.7435.8257.00125.29160.9593.6916.65100.07
P/S Ratio1.752.402.342.882.713.973.082.782.322.251.70
P/B Ratio4.395.905.947.056.779.115.564.923.482.611.30
P/FCF13.8819.0717.0528.7424.6223.9026.0236.9330.4236.2616.61
P/OCF10.7314.7413.2720.0617.2818.7017.8321.7619.2922.4713.44

P/E links to full P/E history page with 30-year chart

IQV EV Ratios

Enterprise-value multiples — capital-structure-neutral measures of total business value

IQVIA Holdings Inc.'s enterprise value stands at 12.4x EBITDA, 31% below its 5-year average of 18.1x. The Healthcare sector median is 14.2x, placing the stock at a 13% discount on an enterprise-value basis.

MetricTTMFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016
EV / Revenue—3.273.153.713.534.764.053.793.293.202.58
EV / EBITDA12.4415.5414.6217.9317.3624.8722.8121.2518.2317.9518.86
EV / EBIT18.6622.9820.7326.1028.5843.9758.3452.6246.2348.5331.36
EV / FCF—25.9922.9437.0832.0628.7134.2750.3543.1551.6825.23

IQV Profitability

Margins and return-on-capital ratios measuring operating efficiency

IQVIA Holdings Inc. earns an operating margin of 14.0%. ROE of 21.4% indicates solid capital efficiency. ROIC of 8.7% represents adequate returns on invested capital.

Margins

Full margin charts and quarterly trend are on the Earnings History page

MetricTTMFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016
Gross Margin26.3%26.3%34.9%35.0%34.9%33.5%34.0%34.2%35.2%35.1%30.3%
Operating Margin14.0%14.0%14.3%13.2%12.5%10.0%6.4%7.0%7.1%7.4%9.4%
Net Profit Margin8.3%8.3%8.9%9.1%7.6%7.0%2.5%1.7%2.5%13.5%1.7%

Return on Capital

MetricTTMFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016
ROE21.4%21.4%22.5%22.9%18.5%15.7%4.4%2.9%3.4%15.2%2.6%
ROA4.8%4.8%5.1%5.2%4.4%3.9%1.2%0.8%1.1%6.0%0.9%
ROIC8.7%8.7%8.9%8.2%7.8%6.1%3.1%3.4%3.2%3.3%5.9%
ROCE11.0%11.0%11.0%9.9%9.2%7.1%3.7%4.1%3.8%3.8%6.2%

IQV Leverage & Debt

Solvency and debt-coverage ratios — lower is generally safer

IQVIA Holdings Inc. carries a Debt/EBITDA ratio of 4.7x, which is highly leveraged (47% above the sector average of 3.2x). Net debt stands at $14.2B ($16.2B total debt minus $2.0B cash). Interest coverage of 3.2x is adequate, though a cyclical earnings downturn could tighten the margin of safety.

MetricTTMFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016
Debt / Equity2.442.442.332.272.262.062.051.921.581.220.81
Debt / EBITDA4.714.714.274.484.444.686.396.085.855.917.73
Net Debt / Equity—2.142.052.052.051.831.771.791.451.110.68
Net Debt / EBITDA4.144.143.764.044.034.175.505.665.385.366.45
Debt / FCF—6.925.898.357.444.818.2613.4212.7215.428.62
Interest Coverage3.183.183.493.174.284.011.901.791.791.853.89

IQV Liquidity & Efficiency

Short-term solvency ratios and asset-utilisation metrics

The current ratio of 0.75x is below 1.0, meaning current liabilities exceed current assets — though the company's $2.0B cash position helps mitigate short-term liquidity concerns. The current ratio has declined from 0.86x to 0.75x over the past 3 years.

MetricTTMFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016
Current Ratio0.750.750.840.860.890.911.121.051.101.221.23
Quick Ratio0.750.750.840.860.890.911.121.051.101.221.23
Cash Ratio0.260.260.260.230.230.280.420.230.270.350.46
Asset Turnover—0.540.570.560.570.560.460.480.460.430.32
Inventory Turnover———————————
Days Sales Outstanding—76.6976.7783.1474.9868.6479.2486.8486.3480.6693.25

IQV Shareholder Yields

Earnings, FCF, buyback, and dividend yields — total returns to shareholders

IQVIA Holdings Inc. returns 4.4% to shareholders annually primarily through share buybacks. The earnings yield of 4.7% (inverse of P/E) provides a useful comparison to bond yields when assessing the stock's relative attractiveness to fixed income.

Dividends

Full dividend history and growth charts are on the Dividend History page

MetricTTMFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016
Dividend Yield———————————
Payout Ratio———————————

Total Shareholder Return Metrics

MetricTTMFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016
Earnings Yield4.7%3.5%3.8%3.2%2.8%1.8%0.8%0.6%1.1%6.0%1.0%
FCF Yield7.2%5.2%5.9%3.5%4.1%4.2%3.8%2.7%3.3%2.8%6.0%
Buyback Yield4.4%3.2%3.7%2.3%3.0%0.7%1.3%3.1%5.8%12.0%9.5%
Total Shareholder Yield4.4%3.2%3.7%2.3%3.0%0.7%1.3%3.1%5.8%12.0%9.5%
Shares Outstanding—$174M$183M$186M$191M$195M$195M$200M$208M$223M$152M

Peer Comparison

Compare IQV with 10 similar companies in its peer group

CompanyMarket CapP/EEV/EBITDAP/FCFGross MarginOp MarginROEROICDebt/EBITDA
IQV logoIQVYou$28B21.412.413.926.3%14.0%21.4%8.7%4.7
CRL logoCRL$9B-63.612.917.230.5%12.6%-4.3%6.3%3.4
ICLR logoICLR$11B50.310.113.026.4%12.3%2.5%6.2%2.5
PRA logoPRA$1B24.919.5—39.4%6.6%4.0%3.2%5.1
MEDP logoMEDP$13B30.122.919.330.1%21.1%70.2%154.9%0.4
VEEV logoVEEV$25B28.219.718.075.5%28.7%13.9%12.9%0.1
INCY logoINCY$20B15.311.614.591.5%26.1%29.9%51.1%0.0
EXAS logoEXAS$20B-95.4—56.169.7%-6.4%-8.7%-3.6%—
HCAT logoHCAT$129M-0.717.3—33.5%-11.6%-58.3%-6.1%11.9
UNH logoUNH$364B30.317.922.618.5%4.2%11.8%9.2%3.4
CVS logoCVS$125B70.714.016.113.8%2.6%2.3%5.0%6.2
Healthcare Median—22.114.218.563.9%-4.3%-32.6%-11.6%3.2

Peer selection based on competitive and market overlap. Compare multiple stocks →

Download Financial Ratios Data

Includes 30+ ratios · 15 years · Updated daily

Consensus-Based Analysis Tools

Full Stock Analysis

Deep dive into IQV consensus models and risk factors.

View Analysis

Intrinsic Valuation

DCF models, multiple analysis, and analyst estimates.

Check Valuation

Historical Returns

10-year return with dividends reinvested.

Calculate

DCA Calculator

See how regular investing compounds over time.

Run Numbers

Peer Comparison

Compare growth, multiples, and margins vs sector.

Compare

IQV — Frequently Asked Questions

Quick answers to the most common questions about buying IQV stock.

What is IQVIA Holdings Inc.'s P/E ratio?

IQVIA Holdings Inc.'s current P/E ratio is 21.4x. The historical average is 57.4x. This places it at the 8th percentile of its historical range.

What is IQVIA Holdings Inc.'s EV/EBITDA?

IQVIA Holdings Inc.'s current EV/EBITDA is 12.4x. This enterprise value multiple compares the company's total value (equity + debt - cash) to its EBITDA. The historical average is 17.5x.

What is IQVIA Holdings Inc.'s ROE?

IQVIA Holdings Inc.'s return on equity (ROE) is 21.4%. This is above the typical threshold of 15-20% considered good for most companies. The historical average is 13.0%.

Is IQV stock overvalued?

Based on historical data, IQVIA Holdings Inc. is trading at a P/E of 21.4x. This is at the 8th percentile of its historical P/E range. Compare with industry peers and growth rates for a complete picture.

What are IQVIA Holdings Inc.'s profit margins?

IQVIA Holdings Inc. has 26.3% gross margin and 14.0% operating margin. Operating margin between 10-20% is typical for established companies.

How much debt does IQVIA Holdings Inc. have?

IQVIA Holdings Inc.'s Debt/EBITDA ratio is 4.7x, indicating high leverage. A ratio above 4x may signal elevated financial risk.